Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 144 % | In vivo antitumor activity was evaluated against L1210 leukemia implanted mice by measuring percent increase in life span after intraperitoneal administration of compound at 16 mg/kg | ChEMBL. | 6546949 |
Activity (functional) | = 144 % | In vivo antitumor activity was evaluated against L1210 leukemia implanted mice by measuring percent increase in life span after intraperitoneal administration of compound at 16 mg/kg | ChEMBL. | 6546949 |
Activity (functional) | = 155 % | In vivo antitumor activity was evaluated against L1210 leukemia implanted mice by measuring percent increase in life span after intraperitoneal administration of compound at 16 mg/kg | ChEMBL. | 6546949 |
Activity (functional) | = 155 % | In vivo antitumor activity was evaluated against L1210 leukemia implanted mice by measuring percent increase in life span after intraperitoneal administration of compound at 16 mg/kg | ChEMBL. | 6546949 |
GI50 (functional) | -7.474 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -6.456 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -6.278 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -6.084 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.747 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.725 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.565 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.34 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.235 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.101 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
ID50 (functional) | = 0.041 uM | Compound was evaluated for its antitumor activity by the inhibition of L1210 murine leukemia dihydrofolate reductase | ChEMBL. | 6546949 |
ID50 (functional) | = 0.041 uM | Compound was evaluated for its antitumor activity by the inhibition of L1210 murine leukemia dihydrofolate reductase | ChEMBL. | 6546949 |
ID50 (functional) | = 0.18 uM | Compound was evaluated for its cytotoxicity against the L1210 murine leukemia cell culture | ChEMBL. | 6546949 |
ID50 (functional) | = 0.18 uM | Compound was evaluated for its cytotoxicity against the L1210 murine leukemia cell culture | ChEMBL. | 6546949 |
Inhibition (binding) | = 59 % | Inhibition of Folyl-polyglutamate synthase from mouse liver | ChEMBL. | 3385729 |
Inhibition (binding) | = 59 % | Inhibition of Folyl-polyglutamate synthase from mouse liver | ChEMBL. | 3385729 |
Ki (binding) | = 188 uM | Inhibition of Folyl-polyglutamate synthase from mouse liver | ChEMBL. | 3385729 |
Ki (binding) | = 188 uM | Inhibition of Folyl-polyglutamate synthase from mouse liver | ChEMBL. | 3385729 |
Ki (binding) | = 198 uM | Compound was evaluated for the binding affinity to mouse liver folyl polyglutamate synthetase. | ChEMBL. | 6546949 |
Ki (binding) | = 198 uM | Compound was evaluated for the binding affinity to mouse liver folyl polyglutamate synthetase. | ChEMBL. | 6546949 |
Survival days (functional) | = 19 | In vivo antitumor activity was evaluated against L1210 leukemia implanted mice by measuring number of survival days after intraperitoneal administration of compound at 16 mg/kg; range 19-21 | ChEMBL. | 6546949 |
Survival days (functional) | = 21 | In vivo antitumor activity was evaluated against L1210 leukemia implanted mice by measuring T/C median after intraperitoneal administration of compound at 16 mg/kg; 21/9 | ChEMBL. | 6546949 |
Survival days (functional) | = 21 | In vivo antitumor activity was evaluated against L1210 leukemia implanted mice by measuring number of survival days after intraperitoneal administration of compound at 32 mg/kg; range 21-24 | ChEMBL. | 6546949 |
Survival days (functional) | = 22 | In vivo antitumor activity was evaluated against L1210 leukemia implanted mice by measuring T/C median after intraperitoneal administration of compound at 32 mg/kg; 22/9 | ChEMBL. | 6546949 |
Weight change (functional) | = -12 % | In vivo antitumor activity was evaluated against L1210 leukemia implanted mice by measuring 7-day weight change after intraperitoneal administration of compound at 32 mg/kg | ChEMBL. | 6546949 |
Weight change (functional) | = -12 % | In vivo antitumor activity was evaluated against L1210 leukemia implanted mice by measuring 7-day weight change after intraperitoneal administration of compound at 32 mg/kg | ChEMBL. | 6546949 |
Weight change (functional) | = -9 % | In vivo antitumor activity was evaluated against L1210 leukemia implanted mice by measuring 7-day weight change after intraperitoneal administration of compound at 16 mg/kg | ChEMBL. | 6546949 |
Weight change (functional) | = -9 % | In vivo antitumor activity was evaluated against L1210 leukemia implanted mice by measuring 7-day weight change after intraperitoneal administration of compound at 16 mg/kg | ChEMBL. | 6546949 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.